))
Ep 65 | IRA Impact on 340B
Manage episode 473036885 series 3374171
Content provided by SpendMend Pharmacy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by SpendMend Pharmacy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this episode, Greg and Rob are joined by Meetali Desai, a pharmacy business leader for a large health system in New England, to discuss thoughts around projecting the impact that IRA-mandated Medicare drug prices will have on 340B covered entities, which will go into effect in January 2026. Meetali shares her approach to quantifying the impact a 340B provider might feel from the intersection between these two federal programs. She’ll also offer her insights into other hot topics in the 340B space. In the intro, the guys will discuss updates in the news, including movement in current litigation between HHS and manufacturers attempting to implement 340B rebate models, as well as some concerns regarding cybersecurity risks in the vendor-space.
Email us your questions and topics recommendations – [email protected]
73 episodes
Share
